-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades BioLife Solutions to Neutral, Lowers Price Target to $31

Benzinga·07/23/2026 10:31:13
Listen to the news
HC Wainwright & Co. analyst Yi Chen downgrades BioLife Solutions (NASDAQ:BLFS) from Buy to Neutral and lowers the price target from $32 to $31.